


Allotar Therapeutics Email Formats
Biotechnology Research • Pittsburgh, Pennsylvania, United States • 1-10 Employees
Key Contact at Allotar Therapeutics
Pemra Doruker
Co-Founder; CEO
Company overview
| Headquarters | Pittsburgh, Pennsylvania, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Drug Discovery, Protein Dynamics, Allotargeting, Conformational Sampling, Next-Generation Therapies, Ultra-Fast Hybrid Simulations |
| Founded | 2025 |
| Employees | 1-10 |
About Allotar Therapeutics
Allotar Therapeutics is a pioneering women-owned biotech company dedicated to transforming drug discovery through its proprietary computational platform. By integrating cutting-edge physics-based simulations with interpretable artificial intelligence, Allotar uniquely captures the dynamic behavior of proteins to identify hidden allosteric sites—regulatory switches that traditional methods often miss. This innovative approach, known as Allotargeting, enables smarter, faster, and more precise drug design, particularly for diseases driven by protein dysfunction and mutations. With a deep commitment to scientific excellence and innovation, Allotar is advancing a robust pipeline of precision therapies aimed at addressing some of the most challenging unmet medical needs.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Allotar Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Allotar Therapeutics has never raised funding before.
Frequently asked questions
4.8
40,000 users



